News
Appointment of Walbrook PR as Financial PR and IR advisor
19 March 2013
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces the appointment of Walbrook PR Ltd as its Financial PR and IR advisor.
Enquiries:
| TyraTech Inc. Alan Reade, Executive Chairman Bruno Jactel, Chief Executive Officer |
www.tyratech.com Tel: +1 919 415 4310 Tel: +1 919 415 4280 |
| Walbrook PR Ltd Bob Huxford Paul Cornelius |
Tel: +44 (0)20 7933 8780 bob.huxford@walbrookpr.com paul.cornelius@walbrookir.com |
Notes to Editors:
TyraTech, Inc. was established in 2004 to utilise its novel technology to fill the unmet and increasing global demand for effective, safe, and natural pesticide technologies for human and animal health.
TyraTech's products incorporate a unique blend of potent natural active ingredients and are available in a number of markets including consumer, commercial, professional pest control, agriculture, human and animal health, vector control and livestock markets.
TyraTech, Inc. made its Initial Public Offering in June 2007 on the AIM section of the London Stock Exchange, where it trades under the symbols 'TYR' and 'TYRU'. Since going public, TyraTech has established partnerships with market leaders in areas such as human health as well as consumer and commercial pest control operators.
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.